Archive: 14/09/2020
Gilead in $21 bn deal for Immunomedics
US pharmaceutical giant Gilead Sciences confirmed Sunday that it is buying American biotech firm Immunomedics, which makes a breast cancer drug, for $21 billion.
Sep 14, 2020
US pharmaceutical giant Gilead Sciences confirmed Sunday that it is buying American biotech firm Immunomedics, which makes a breast cancer drug, for $21 billion.
Sep 14, 2020